New test for prostate cancer

Testing may involve a blood sample, urine, imaging, a prostate biopsy, or analysis of tumour tissue. The purpose differs: some tests help decide whether biopsy is needed, some describe the cancer after diagnosis, and some look for changes that could affect treatment selection. A result is interpreted alongside examination findings, PSA trends, imaging, biopsy grade, and overall health.

A positive or abnormal result is not the same as a diagnosis by itself, and a reassuring result cannot answer every clinical question. Ask whether the test is diagnostic, a risk assessment, or treatment-planning information, and what action follows each possible result.

Before testing, ask what sample is needed, whether preparation is required, how long interpretation may take, and whether the result changes the next appointment. Share medicines, infections, urinary symptoms, and previous biopsy or imaging reports. Difficulty passing urine should be assessed separately because it can have several causes.

If cancer is confirmed, the team may use test information to discuss monitoring, surgery, radiotherapy, or systemic treatment. The [Prostate Cancer](/conditions/prostate-cancer/) page gives broader context, while [Genomic Tumour Profiling](/treatments/diagnostics-and-staging/genomic-tumour-profiling/) explains how tumour characteristics can inform decisions.

Seek urgent medical help for inability to pass urine, severe pain, fever after a biopsy, heavy bleeding, fainting, or new leg weakness. Contact the clinic about persistent blood in urine or semen, worsening urinary symptoms, or a result you do not understand.

What question is this test designed to answer? What would change if the result is abnormal or reassuring? Is tissue needed? How does it fit with my PSA, scan, and biopsy findings? Who will explain the report and arrange follow-up?